Mass treatment with azithromycin may decrease yaws cases in Ghana

March 22, 2018, Public Library of Science

A single round of total-community treatment (TCT) with the antibiotic azithromycin applied to affected rural communities could significantly decrease yaws among the population one year later, according to study published in PLOS Neglected Tropical Diseases by Kingsley Bampoe Asiedu, of the World Health Organization (WHO) and colleagues.

Yaws is a disease which affects mainly children and is diagnosed by the presence of skin ulcers and a reactive syphilis serology, but this can be confused clinically with ulcers caused by other infections, such as a Haemophilus ducreyi infection. In 2012, the WHO devised a new yaws eradication strategy, also known as the Morges Strategy, which recommended the TCT of yaws-affected communities using single doses of oral azithromycin followed by ongoing active surveillance and total targeted treatment of cases and contacts.

Asiedu and colleagues conducted a survey of 2,909 schoolchildren before and one year after the TCT intervention in Ghana in order to assess the impact of the mass treatment. The researchers found that the provision of mass azithromycin administration given as a single oral dose of 30 mg/kg and up to a maximum dose of 2 g is effective in reducing both the rates of seropositivity and the presence of serologically positive skin lesions consistent with yaws one year after administration. Azithromycin is also effective against H. ducreyi.

While the sample population of schoolchildren did not include the poorest children who may not attend school, the routine surveillance data from the District Health Information Management System confirmed the overall decrease of yaws-like cases seen in the Ghanaian sub-district one year after the TCT. The authors note that yaws-like lesions caused by H. ducreyi or other unknown pathogens may continue to persist after a single-round of mass treatment, and therefore they suggest that it may be necessary to devise new management protocols for non-yaws / non-H. ducreyi lesions following the successful elimination of yaws through TCT.

"Although one round of TCT was unable to stop transmission, we achieved a significant reduction in the disease. With little effort through total targeted , or perhaps another round of TCT, we could possibly end yaws," notes Dr. Cynthia Kwakye-Maclean, Programme Manager of Ghana Yaws Eradication Programme.

Explore further: Study identifies how to improve WHO eradication strategy for skin disease

More information: Abdulai AA, Agana-Nsiire P, Biney F, Kwakye-Maclean C, Kyei-Faried S, Amponsa-Achiano K, et al. (2018) Community-based mass treatment with azithromycin for the elimination of yaws in Ghana—Results of a pilot study. PLoS Negl Trop Dis 12(3): e0006303. doi.org/10.1371/journal.pntd.0006303

Related Stories

Study identifies how to improve WHO eradication strategy for skin disease

February 8, 2018
An international research collaboration published in The Lancet has found crucial evidence that could help to improve the current World Health Organization (WHO) strategy to eradicate yaws—a chronic disfiguring and debilitating ...

Expert urges action to eradicate yaws, tropical disease

March 19, 2015
Half a century ago, a concentrated global effort nearly wiped a disfiguring tropical disease from the face of the earth. Now, says Case Western Reserve's James W. Kazura, MD, it's time to complete the work.

Why treating animals may be important in fighting resurgent tropical disease

April 12, 2017
As the World Health Organization steps up its efforts to eradicate a once-rampant tropical disease, a University of Washington study suggests that monitoring, and potentially treating, the monkeys that co-exist with humans ...

WHO urges billions to fight neglected tropical diseases

February 19, 2015
The World Health Organization on Thursday urged countries to invest billions of dollars to tackle 17 neglected tropical diseases—including dengue fever, leprosy and sleeping sickness—which kill 500,000 people globally ...

Recommended for you

Cancer drug helps treat tuberculosis by restoring leaky blood vessels

April 26, 2018
Biomedical engineers have discovered an unlikely potential ally in the global fight against tuberculosis—an FDA-approved drug originally designed to treat cancer.

Molecule may help tame virulent bacteria and prevent infection

April 26, 2018
According to the U.S. Centers for Disease Control and Prevention, about one in three humans carries Staphylococcus aureus, or "staph," in our noses, and 2 percent of us carry the dreaded methicillin-resistant (MRSA) strain ...

Antibody 'cocktail' can prevent Zika infection but is not effective for treatment of fetuses

April 26, 2018
A "cocktail" of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School ...

E. coli—are we measuring the wrong thing?

April 25, 2018
A sepsis awareness and management programme has demonstrated overall success in terms of improved sepsis detection, but has led to an increase in the number of E. coli blood stream infection cases presented, calling into ...

Malaria study reveals gene variants linked to risk of disease

April 25, 2018
Many people of African heritage are protected against malaria by inheriting a particular version of a gene, a large-scale study has shown.

Commonly prescribed heartburn drug linked to pneumonia in older adults

April 24, 2018
Researchers at the University of Exeter have found a statistical link between pneumonia in older people and a group of medicines commonly used to neutralise stomach acid in people with heartburn or stomach ulcers. Although ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.